KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ONCY
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Oncolytics Biotech Inc. stock downgraded to Hold/Accumulate
(Updated on Apr 26, 2024)

Buy or Hold candidate since Apr 25, 2024 Gain 0.93% PDF

The Oncolytics Biotech Inc. stock price gained 0.93% on the last trading day (Friday, 26th Apr 2024), rising from $1.08 to $1.09. During the last trading day the stock fluctuated 3.77% from a day low at $1.06 to a day high of $1.10. The price has risen in 5 of the last 10 days but is still down by -4.39% for this period. Volume fell on the last day by -83 thousand shares and in total, 219 thousand shares were bought and sold for approximately $238.64 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.55% during the next 3 months and, with a 90% probability hold a price between $0.84 and $1.12 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ONCY Signals & Forecast

The Oncolytics Biotech Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $1.06 and $1.07. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 09, 2024, and so far it has fallen -6.03%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation A sell signal from a double top formation was found on Tuesday, April 09, 2024 and based on theory for this formation the price should fall by -18.74% to $0.89 within 35 trading days since signal was issued (Monday, April 29, 2024).

Support, Risk & Stop-loss for Oncolytics Biotech Inc. stock

Oncolytics Biotech Inc. finds support from accumulated volume at $1.05 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0400 between high and low, or 3.77%. For the last week the stock has had daily average volatility of 4.43%.

Our recommended stop-loss: $1.04 (-4.56%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (ONCY) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Oncolytics Biotech Inc. to open at $1.08, and during the day (based on 14 day Average True Range), to move between $1.03 and $1.15, which gives a possible trading interval of +/-$0.0625 (+/-5.73%) up or down from last closing price. If Oncolytics Biotech Inc. takes out the full calculated possible swing range there will be an estimated 11.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.05 (3.67%) than the resistance at $1.14 (4.59%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Oncolytics Biotech Inc. will release earnings BMO on Friday, May 03, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.0900. We will update the financials statements for Oncolytics Biotech Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 10.44% in the first trading day after earnings release.

Is Oncolytics Biotech Inc. stock A Buy?

Oncolytics Biotech Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.854 Hold/Accumulate Downgraded

Predicted Opening Price for Oncolytics Biotech Inc. of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$1.08 ( 0.612%) $1.09

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ONCY

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.12 3.06 %
R2 1.11 1.66 %
R1 1.10 0.790 %
Current price: 1.09
Support S1 1.07 -2.01 %
S2 1.06 -2.88 %
S3 1.04 -4.28 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.16 6.42 %
R2 1.15 5.50 %
R1 1.14 4.59 %
Current price 1.09
Support S1 1.05 -3.67%
S2 1.04 -4.59%
S3 1.02 -6.42%

FAQ

What is the symbol for Oncolytics Biotech Inc. Stock and on which exchange is it traded?
The symbol for Oncolytics Biotech Inc. is ONCY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Oncolytics Biotech Inc. Stock?
Oncolytics Biotech Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Oncolytics Biotech Inc. Stock?
Oncolytics Biotech Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Oncolytics Biotech Inc. Stock.

What's the current price of Oncolytics Biotech Inc. Stock?
As of the end of day on the Apr 26, 2024, the price of an Oncolytics Biotech Inc. (ONCY) share was $1.09.

What is the 52-week high and low for Oncolytics Biotech Inc. Stock?
The 52-week high for Oncolytics Biotech Inc. Stock is $3.39 and the 52-week low is $0.89.

What is the market capitalization of Oncolytics Biotech Inc. Stock?
As of the Apr 26, 2024, the market capitalization of Oncolytics Biotech Inc. is 82.208M.

When is the next earnings date for Oncolytics Biotech Inc.?
The upcoming earnings date for Oncolytics Biotech Inc. is May 03, 2024.
Click to get the best stock tips daily for free!

About Oncolytics Biotech Inc.

Oncolytics Biotech. Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with ... ONCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT